Dr. Moreno obtained his B.S. and M.S. in Aeronautics and Astronautics from MIT, and worked for NASA before he earned his PhD in Genetics and Molecular Biology from Emory University in 1998. He is Associate Professor of Pathology & Laboratory Medicine and Biomedical Informatics at Emory University, where he is a member of the Winship Cancer Institute and the Director of the Cancer Biology PhD Program and the 4+1 Cancer Biology and Translational Oncology MS Program. He specializes in cancer bioinformatics and cancer genomics, and his laboratory has used whole genome expression analysis and next-generation sequencing to identify biomarkers of aggressive disease in prostate cancer. He is Section Editor-in-Chief of the Cancer Biomarkers section of the journal Cancers. He is author of over 100 peer-reviewed scientific publications and a co-inventor on a patent application for a system to detect biomarkers using piezoelectric resonators. His current work focuses on development of novel therapeutic targets in prostate cancer and understanding the molecular basis for tumor heterogeneity and metastasis.